Urologic Imaging

What Is the Best Imaging for Asymptomatic Bilateral Hydronephrosis in Adults?

·
What Is the Best Imaging for Asymptomatic Bilateral Hydronephrosis in Adults?

A 68-year-old male with a history of hypertension comes to your clinic for a routine follow-up. An abdominal ultrasound, ordered to screen for an aortic aneurysm, incidentally reveals moderate bilateral hydronephrosis. His creatinine is stable at 1.1 mg/dL, and he denies any flank pain, urinary symptoms, or constitutional signs. You are now faced with a significant finding in an asymptomatic patient, and the next step is to identify the underlying cause of the obstruction. This article provides a focused, evidence-based workflow for this exact clinical question: what is the appropriate initial imaging for an adult with asymptomatic bilateral hydronephrosis or asymptomatic hydronephrosis in a solitary kidney? According to the American College of Radiology (ACR) Appropriateness Criteria, Magnetic Resonance Urography (MRU) without and with IV contrast is rated Usually Appropriate for this presentation.

Who Fits This Clinical Scenario?

This guidance is specifically for an adult patient who is asymptomatic and has newly discovered bilateral hydronephrosis or hydronephrosis in a solitary kidney. The cause is unknown based on the initial imaging, which is often an ultrasound or a non-contrast CT performed for another reason. The key inclusion criteria are:

  • Patient: Adult.
  • Symptoms: Asymptomatic. The patient has no flank pain, fever, signs of infection, or acute kidney injury.
  • Finding: Bilateral hydronephrosis OR hydronephrosis in a solitary kidney.
  • History: The cause of the hydronephrosis is not apparent from prior imaging or clinical history.

This workflow does not apply to several similar but distinct clinical situations. If your patient presents differently, they will likely require a different imaging approach. Exclusions include:

  • Symptomatic Patients: An adult with flank pain, fever, or a rising creatinine requires a more urgent evaluation, often starting with CT. This is covered in the symptomatic hydronephrosis scenario.
  • Unilateral Hydronephrosis: If the finding is isolated to one kidney in a patient with two kidneys, the differential diagnosis shifts toward causes like a ureteral stone or stricture, which follows a separate diagnostic pathway.
  • Pregnant Patients: Physiologic hydronephrosis is common in pregnancy, and the imaging workup is significantly different to minimize fetal risk.

What Diagnoses Are You Working Up in This Scenario?

The presence of bilateral hydronephrosis (or hydronephrosis in a solitary kidney) points toward an obstructive process at or below the level of the bladder trigone, affecting both ureters simultaneously. The differential diagnosis is centered on causes of chronic, low-grade obstruction.

Bladder Outlet Obstruction (BOO) is the most common cause in men, typically from benign prostatic hyperplasia (BPH). The enlarged prostate compresses the urethra, leading to chronically elevated bladder pressure, bladder wall thickening, and eventual back-pressure on both ureters and kidneys. In women, BOO is less common but can result from pelvic organ prolapse or a large uterine fibroid.

Pelvic Malignancy is a critical consideration. An advanced primary cancer of the prostate, bladder, cervix, uterus, or rectum can invade the bladder base or grow large enough to cause extrinsic compression of both ureters. Metastatic disease to pelvic lymph nodes can also cause bilateral obstruction.

Retroperitoneal Fibrosis (RPF) is an uncommon but important diagnosis. This condition involves the proliferation of fibrous tissue in the retroperitoneum, which can encase and constrict the ureters. While often idiopathic (Ormond’s disease), it can be secondary to malignancy, certain medications, or inflammatory conditions. It typically presents insidiously.

Neurogenic Bladder can also lead to bilateral hydronephrosis. In this functional obstruction, nerve damage (from diabetes, spinal cord injury, or other neurologic diseases) impairs bladder emptying, leading to high-pressure urinary retention and subsequent damage to the upper tracts.

Why Is MR Urography the Recommended Study for This Presentation?

For an asymptomatic patient with bilateral hydronephrosis, the diagnostic goal is to gain a comprehensive anatomical and functional understanding of the urinary tract without exposing the patient to unnecessary radiation. This is why MR Urography (MRU) without and with IV contrast is the top recommended study.

The ACR rates MRU without and with IV contrast as Usually Appropriate. Its primary advantage is its superior soft-tissue contrast, which allows for detailed evaluation of the prostate, bladder wall, pelvic organs, and retroperitoneum—the key areas where the cause of obstruction is likely to be found. MRU can clearly delineate an enlarged prostate, identify a pelvic mass, or show the characteristic sheet-like tissue enhancement of retroperitoneal fibrosis. Furthermore, the “urography” component involves T2-weighted sequences that visualize the fluid-filled urinary tract and post-contrast excretory phase imaging that provides functional information on drainage. Critically, MRU achieves this with no ionizing radiation (0 mSv), a significant benefit for a condition that may be benign and require surveillance imaging.

Alternative studies are rated lower for specific reasons in this context:

  • CT Urography (CTU) without and with IV contrast is rated May be appropriate (Disagreement). While CTU provides excellent anatomical detail and is often faster and more widely available than MRU, it delivers a substantial radiation dose (☢☢☢☢ 10-30 mSv). Given that the patient is asymptomatic and the condition may be chronic and non-malignant, avoiding this radiation exposure is preferable.
  • Ultrasound (US) of the kidneys and bladder is rated Usually not appropriate as the next diagnostic step. Ultrasound is an excellent initial screening tool and was likely the modality that first identified the hydronephrosis. However, it has significant limitations in visualizing the mid-ureters and the retroperitoneum, making it insufficient for determining the underlying cause of the obstruction.

When ordering the study, it is crucial to specify “MR Urogram” rather than a standard “MRI Pelvis” to ensure the protocol includes the necessary T2-weighted hydrographic sequences and post-contrast excretory phases for functional assessment.

What’s Next After MRU? Downstream Workflow

The results of the MRU will guide the subsequent clinical pathway, which almost always involves a referral to a urologist for further management.

  • If the MRU is positive for Bladder Outlet Obstruction (e.g., severe BPH): The next step is typically functional testing with uroflowmetry and post-void residual measurement to confirm the degree of obstruction. The patient would then be managed by urology with medical therapy (e.g., alpha-blockers) or surgical intervention (e.g., TURP).
  • If the MRU is positive for a suspicious pelvic mass or retroperitoneal fibrosis: This finding requires an urgent referral to urology and potentially medical or radiation oncology. A tissue biopsy is often the next step to establish a definitive diagnosis and guide cancer treatment or management of RPF.
  • If the MRU is negative or indeterminate: If the MRU shows no clear anatomical cause of obstruction, a functional cause like neurogenic bladder should be strongly considered. The downstream workflow would involve a urology consultation for urodynamic studies to assess bladder function and pressures.
  • If the MRU suggests ureteral strictures: While less common bilaterally, if strictures are identified, the patient may need retrograde pyelography for better delineation, followed by endoscopic or surgical management.

In all cases, the primary role of the imaging is to triage the patient to the correct specialist and inform the next diagnostic or therapeutic procedure.

Pitfalls to Avoid (and When to Get Help)

Navigating this clinical scenario requires careful consideration to avoid common missteps.

  1. Dismissing the finding: Do not assume asymptomatic hydronephrosis is benign. Chronic silent obstruction can lead to irreversible loss of renal function.
  2. Repeating the wrong test: Ordering another ultrasound after one has already shown hydronephrosis is a low-yield step. The goal is to find the cause, which US is poorly suited to do.
  3. Ignoring renal function: While the patient may be asymptomatic with normal creatinine initially, this can change. Always check renal function before ordering contrast-enhanced studies and monitor it during the workup.
  4. Delaying referral: Once imaging confirms a significant anatomical obstruction (e.g., a mass), prompt referral to urology is essential to prevent further renal damage and to expedite diagnosis and treatment.

If the patient develops symptoms such as pain, fever, or a rapid rise in creatinine at any point, the workup should be escalated immediately, as this may represent an acute-on-chronic obstruction or infection requiring urgent intervention.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to hydronephrosis found on prior imaging, please consult our parent guide. For other tools to help with imaging decisions, see the resources below.

Frequently Asked Questions

Why is ultrasound ‘Usually Not Appropriate’ for this workup if it’s what found the hydronephrosis?

Ultrasound is an excellent screening tool for detecting the presence of hydronephrosis, but it is not the appropriate next step for determining the cause. It has limited ability to visualize the full length of the ureters and the deep pelvic structures where the obstruction is likely located (e.g., prostate, bladder base, retroperitoneum). After hydronephrosis is found, a more advanced cross-sectional imaging study like MRU is needed to find the ‘why’.

My patient has a GFR of 40. Can I still order an MRU with contrast?

The use of gadolinium-based contrast agents (GBCAs) in patients with reduced renal function requires careful consideration due to the risk of nephrogenic systemic fibrosis (NSF). However, with modern macrocyclic GBCAs, the risk is extremely low, even in patients with moderate chronic kidney disease (GFR 30-44 mL/min/1.73m²). The decision should be made in consultation with the radiologist, weighing the diagnostic benefit against the very small risk. An MRU without contrast is also an option, rated ‘May be appropriate’ by the ACR, though it may be less effective at characterizing masses or retroperitoneal fibrosis.

What if the patient is asymptomatic but has a very high creatinine?

If a patient with newly discovered bilateral hydronephrosis has a significantly elevated creatinine, they are no longer considered truly ‘asymptomatic’ from a clinical standpoint, as they have evidence of organ dysfunction (acute or chronic kidney injury). This situation is more urgent and may require inpatient admission and consultation with both nephrology and urology for potential urgent bladder decompression (e.g., Foley catheter placement) while the diagnostic imaging is being arranged.

Is a nuclear medicine renal scan (MAG3) a good alternative to MRU?

A MAG3 renal scan is also rated ‘Usually Appropriate’ by the ACR for this scenario. It is a functional study that excels at quantifying differential renal function and assessing the degree of obstruction (e.g., by measuring drainage halftime after diuretic administration). However, it provides very limited anatomical information. It is an excellent choice if the primary question is functional—’Is this obstruction causing significant renal damage?’—but MRU is superior if the primary question is anatomical—’What is the cause of this obstruction?’ Often, MRU is performed first to find the cause, and a MAG3 scan may be used later for functional follow-up.

The MRU report is normal. What could be the cause of the hydronephrosis?

If a high-quality MRU shows no anatomical cause for obstruction, the focus should shift to functional or intermittent causes. The most likely diagnosis in this case is a functional bladder outlet obstruction, such as from a neurogenic bladder. The next step would be a referral to a urologist for urodynamic testing to measure bladder pressures and assess emptying efficiency. Less common causes could include vesicoureteral reflux, though this is more typical in children.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026